Phaseline

Targets › PBPN

PBPN: drug programs, companies and trials

2 programs from 2 companies in 2 trials: 2 Phase 4; Infectious disease, Respiratory; next expected readout Jun 2028.

Open in Phaseline: the race on PBPN, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Scandinavian Critical Care Trials GroupTazobactam
Bacterial beta-lactamase TEM inhibitor
PBPNPhase 4SepsisJun 2028
Tejs Ehlers KlugPenicillin G
Bacterial penicillin-binding protein inhibitor
PBPNPhase 4Acute TonsillitisDec 2028

Conditions

Sepsis (1) Acute Tonsillitis (1)

Modalities

small molecule (2)

Companies

Scandinavian Critical Care Trials Group (1) Tejs Ehlers Klug (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.